| Condition | Indicated | Relationship Strength | Studies | Trials |
|---|
Innate Inflammatory Response
[description not available] | 0 | 2.98 | 4 | 0 |
Diabetes Mellitus
A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE. | 0 | 2.17 | 1 | 0 |
Inflammation
A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. | 0 | 2.98 | 4 | 0 |
Airflow Obstruction, Chronic
[description not available] | 0 | 3.09 | 1 | 0 |
Asthma, Bronchial
[description not available] | 0 | 3.09 | 1 | 0 |
Disease Models, Animal
Naturally-occurring or experimentally-induced animal diseases with pathological processes analogous to human diseases. | 0 | 4.48 | 8 | 0 |
Acute Respiratory Distress Syndrome
[description not available] | 0 | 3.09 | 1 | 0 |
Asthma
A form of bronchial disorder with three distinct components: airway hyper-responsiveness (RESPIRATORY HYPERSENSITIVITY), airway INFLAMMATION, and intermittent AIRWAY OBSTRUCTION. It is characterized by spasmodic contraction of airway smooth muscle, WHEEZING, and dyspnea (DYSPNEA, PAROXYSMAL). | 0 | 3.09 | 1 | 0 |
Respiratory Distress Syndrome
A syndrome characterized by progressive life-threatening RESPIRATORY INSUFFICIENCY in the absence of known LUNG DISEASES, usually following a systemic insult such as surgery or major TRAUMA. | 0 | 3.09 | 1 | 0 |
Pulmonary Disease, Chronic Obstructive
A disease of chronic diffuse irreversible airflow obstruction. Subcategories of COPD include CHRONIC BRONCHITIS and PULMONARY EMPHYSEMA. | 0 | 3.09 | 1 | 0 |
Cerebral Ischemia
[description not available] | 0 | 2.21 | 1 | 0 |
Brain Ischemia
Localized reduction of blood flow to brain tissue due to arterial obstruction or systemic hypoperfusion. This frequently occurs in conjunction with brain hypoxia (HYPOXIA, BRAIN). Prolonged ischemia is associated with BRAIN INFARCTION. | 0 | 2.21 | 1 | 0 |
Injury, Ischemia-Reperfusion
[description not available] | 0 | 2.07 | 1 | 0 |
Ischemia
A hypoperfusion of the BLOOD through an organ or tissue caused by a PATHOLOGIC CONSTRICTION or obstruction of its BLOOD VESSELS, or an absence of BLOOD CIRCULATION. | 0 | 2.07 | 1 | 0 |
Reperfusion Injury
Adverse functional, metabolic, or structural changes in tissues that result from the restoration of blood flow to the tissue (REPERFUSION) following ISCHEMIA. | 0 | 2.07 | 1 | 0 |
Necrotizing Enterocolitis
[description not available] | 0 | 2.08 | 1 | 0 |
Enterocolitis, Necrotizing
ENTEROCOLITIS with extensive ulceration (ULCER) and NECROSIS. It is observed primarily in LOW BIRTH WEIGHT INFANT. | 0 | 2.08 | 1 | 0 |
Infections, Pseudomonas
[description not available] | 0 | 2.08 | 1 | 0 |
Pseudomonas Infections
Infections with bacteria of the genus PSEUDOMONAS. | 0 | 2.08 | 1 | 0 |
Injuries, Soft Tissue
[description not available] | 0 | 2.1 | 1 | 0 |
Hemorrhagic Shock
[description not available] | 0 | 2.1 | 1 | 0 |
Lung Injury, Acute
[description not available] | 0 | 2.1 | 1 | 0 |
Grippe
[description not available] | 0 | 2.1 | 1 | 0 |
Infections, Orthomyxoviridae
[description not available] | 0 | 2.1 | 1 | 0 |
Influenza, Human
An acute viral infection in humans involving the respiratory tract. It is marked by inflammation of the NASAL MUCOSA; the PHARYNX; and conjunctiva, and by headache and severe, often generalized, myalgia. | 0 | 2.1 | 1 | 0 |
Orthomyxoviridae Infections
Virus diseases caused by the ORTHOMYXOVIRIDAE. | 0 | 2.1 | 1 | 0 |
Acute Lung Injury
A condition of lung damage that is characterized by bilateral pulmonary infiltrates (PULMONARY EDEMA) rich in NEUTROPHILS, and in the absence of clinical HEART FAILURE. This can represent a spectrum of pulmonary lesions, endothelial and epithelial, due to numerous factors (physical, chemical, or biological). | 0 | 2.1 | 1 | 0 |
Blood Poisoning
[description not available] | 0 | 6.16 | 6 | 2 |
E coli Infections
[description not available] | 0 | 2.46 | 2 | 0 |
Primary Peritonitis
[description not available] | 0 | 2.1 | 1 | 0 |
Escherichia coli Infections
Infections with bacteria of the species ESCHERICHIA COLI. | 0 | 2.46 | 2 | 0 |
Peritonitis
INFLAMMATION of the PERITONEUM lining the ABDOMINAL CAVITY as the result of infectious, autoimmune, or chemical processes. Primary peritonitis is due to infection of the PERITONEAL CAVITY via hematogenous or lymphatic spread and without intra-abdominal source. Secondary peritonitis arises from the ABDOMINAL CAVITY itself through RUPTURE or ABSCESS of intra-abdominal organs. | 0 | 2.1 | 1 | 0 |
Sepsis
Systemic inflammatory response syndrome with a proven or suspected infectious etiology. When sepsis is associated with organ dysfunction distant from the site of infection, it is called severe sepsis. When sepsis is accompanied by HYPOTENSION despite adequate fluid infusion, it is called SEPTIC SHOCK. | 1 | 8.16 | 6 | 2 |
Body Weight
The mass or quantity of heaviness of an individual. It is expressed by units of pounds or kilograms. | 0 | 2.11 | 1 | 0 |
Insulin Sensitivity
[description not available] | 0 | 2.11 | 1 | 0 |
Insulin Resistance
Diminished effectiveness of INSULIN in lowering blood sugar levels: requiring the use of 200 units or more of insulin per day to prevent HYPERGLYCEMIA or KETOSIS. | 0 | 2.11 | 1 | 0 |
Obesity
A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY). | 0 | 2.11 | 1 | 0 |
Periphlebitis
Periphlebitis is inflammation of the outer coat of a vein or of tissues surrounding the vein. | 0 | 2.04 | 1 | 0 |
Phlebitis
Inflammation of a vein, often a vein in the leg. Phlebitis associated with a blood clot is called (THROMBOPHLEBITIS). | 0 | 2.04 | 1 | 0 |
Endotoxemia
A condition characterized by the presence of ENDOTOXINS in the blood. On lysis, the outer cell wall of gram-negative bacteria enters the systemic circulation and initiates a pathophysiologic cascade of pro-inflammatory mediators. | 0 | 5.98 | 5 | 2 |
Acute Hepatic Failure
[description not available] | 0 | 2.46 | 2 | 0 |
Liver Failure, Acute
A form of rapid-onset LIVER FAILURE, also known as fulminant hepatic failure, caused by severe liver injury or massive loss of HEPATOCYTES. It is characterized by sudden development of liver dysfunction and JAUNDICE. Acute liver failure may progress to exhibit cerebral dysfunction even HEPATIC COMA depending on the etiology that includes hepatic ISCHEMIA, drug toxicity, malignant infiltration, and viral hepatitis such as post-transfusion HEPATITIS B and HEPATITIS C. | 0 | 2.46 | 2 | 0 |
Bacterial Disease
[description not available] | 0 | 3.44 | 1 | 1 |
Critical Illness
A disease or state in which death is possible or imminent. | 0 | 4.41 | 2 | 2 |
Bacterial Infections
Infections by bacteria, general or unspecified. | 0 | 3.44 | 1 | 1 |
Infections, Respiratory Syncytial Virus
[description not available] | 0 | 2.07 | 1 | 0 |
Respiratory Syncytial Virus Infections
Pneumovirus infections caused by the RESPIRATORY SYNCYTIAL VIRUSES. Humans and cattle are most affected but infections in goats and sheep have been reported. | 0 | 2.07 | 1 | 0 |
Endotoxin Shock
[description not available] | 0 | 2.42 | 2 | 0 |
Shock, Septic
Sepsis associated with HYPOTENSION or hypoperfusion despite adequate fluid resuscitation. Perfusion abnormalities may include but are not limited to LACTIC ACIDOSIS; OLIGURIA; or acute alteration in mental status. | 0 | 2.42 | 2 | 0 |
Tachyarrhythmia
[description not available] | 0 | 3.4 | 1 | 1 |
Tachycardia
Abnormally rapid heartbeat, usually with a HEART RATE above 100 beats per minute for adults. Tachycardia accompanied by disturbance in the cardiac depolarization (cardiac arrhythmia) is called tachyarrhythmia. | 0 | 3.4 | 1 | 1 |
Cirrhosis, Liver
[description not available] | 0 | 3.4 | 1 | 1 |
Liver Cirrhosis
Liver disease in which the normal microcirculation, the gross vascular anatomy, and the hepatic architecture have been variably destroyed and altered with fibrous septa surrounding regenerated or regenerating parenchymal nodules. | 0 | 3.4 | 1 | 1 |
Experimental Lung Inflammation
Inflammation of any part, segment or lobe, of the lung parenchyma. | 0 | 2.02 | 1 | 0 |
Airway Hyper-Responsiveness
[description not available] | 0 | 2.02 | 1 | 0 |
Pneumonia
Infection of the lung often accompanied by inflammation. | 0 | 2.02 | 1 | 0 |
Cardiomyopathies, Primary
[description not available] | 0 | 2.03 | 1 | 0 |
Bacterial Infections, Gram-Negative
[description not available] | 0 | 2.03 | 1 | 0 |
Cardiomyopathies
A group of diseases in which the dominant feature is the involvement of the CARDIAC MUSCLE itself. Cardiomyopathies are classified according to their predominant pathophysiological features (DILATED CARDIOMYOPATHY; HYPERTROPHIC CARDIOMYOPATHY; RESTRICTIVE CARDIOMYOPATHY) or their etiological/pathological factors (CARDIOMYOPATHY, ALCOHOLIC; ENDOCARDIAL FIBROELASTOSIS). | 0 | 2.03 | 1 | 0 |
Gram-Negative Bacterial Infections
Infections caused by bacteria that show up as pink (negative) when treated by the gram-staining method. | 0 | 2.03 | 1 | 0 |
Complication, Postoperative
[description not available] | 0 | 3.42 | 1 | 1 |
Postoperative Complications
Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. | 0 | 3.42 | 1 | 1 |
Sensitivity and Specificity
Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) | 0 | 2 | 1 | 0 |